Refine by
Disease Recurrence Suppliers & Manufacturers
24 companies found
based inSan Francisco, CALIFORNIA (USA)
Motic Digital Pathology addresses the growing global pathology care gap by making digital medicine approachable for hospitals, labs, and doctors everywhere. We promote adoption of telepathology through our innovative, cost-effective solutions ...
based inMenlo Park, CALIFORNIA (USA)
Intersect ENT (NASDAQ: XENT) is a medical technology company dedicated to advancing the treatment of ear, nose and throat (ENT) conditions through evidence-based innovation, providing physicians with solutions to overcome clinical challenges and ...
based inGliwice, POLAND
Graylight Imaging specializes in the development of sophisticated medical imaging software solutions tailored to specific client needs. The company offers a range of services, including custom AI-based algorithms, 3D modeling and visualization, deep ...
The data analysis and interpretation phase involves building models to answer specific clinical questions, such as predicting therapy benefit or disease recurrence risk. Leveraging radiomics can aid in better ...
based inTrieste, ITALY
Today Eurospital manufactures and commercializes pharmaceutical products, medical-surgical and diagnostic devices and a completely new line of gluten-free products. Throughout the years it extended its range of action by implementing strategic ...
The identification of tissue transglutaminase as the antigen responsible for endomysial positivity has opened up new horizons for the serological diagnosis of celiac disease. Today the determination of anti-tTG antibodies is the reference test for ...
based inDunedin,, NEW ZEALAND
Pacific Edge is a cancer diagnostics company. We specialise in discovering, building and commercialising innovative cancer diagnostic tests that can contribute to a clinically meaningful difference in the detection and management of cancer. Our ...
based inOslo, NORWAY
Bio-Me is Setting the Standard for Routine Microbiome Analysis. Gut microbiome research has become essential to almost every medical research field. Next-generation sequencing (NGS) technologies have been crucial in enabling a breakthrough in our ...
PMP™ technology – Bridging the gap between clinical research and clinical practice by translating knowledge into actionable information. Microbiome Analysis Services for Pharma and Drug Developers. Bio-Me’s Precision Microbiome ...
based inSan Diego, CALIFORNIA (USA)
Invivoscribe is a global leader in molecular diagnostics, providing a comprehensive range of standardized, CE-marked in vitro diagnostic products and companion diagnostics for hematology-oncology. The company's offerings include research use only ...
based inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Support treatment decisions with comprehensive tumor profiling. Gain deep insight into the tumor’s genomic alterations and oncology biomarkers with Altera. The detailed sequencing report includes FDA-approved treatments, novel treatment ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
2-(Aminomethyl)phenol (2-Hydroxybenzylamine), a selective dicarbonyl scavenger, is an antioxidant and scavanger of free radicals and isolevuglandins (IsoLGs). 2-(Aminomethyl)phenol can be used in the research of inflammation and cardiovascular ...
based inGuildford, UNITED KINGDOM
Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that ...
CancertrackTM is a non-invasive blood based investigation that detects cancer derived biomarkers with ultra-high precision, specificity and reliability. CancertrackTM can be used to monitor the disease /recurrence ...
based inParis, FRANCE
Founded in 2011, Endodiag is specialized in the development of products and services aimed at improving the diagnosis of endometriosis, a complex and poorly known disease, affecting yet 10% of women of reproductive age (over 180 million patients ...
Endodiag has built a regulatory compliant biobank of more than 1000 human biological samples, including fixed biopsies, serum, plasma and peritoneal fluid samples, as well as endometriosis primary cell cultures and endometriosis derived cell lines. ...
based inNewtown, PENNSYLVANIA (USA)
Formely known as Onconova Therapeutics, Inc. Traws Pharma is a clinical stage biopharmaceutical company developing small molecule oral product candidates for respiratory viral diseases and cancer. In the viral respiratory disease space, Traws Pharma ...
based inWuhan, CHINA
Mulei (Wuhan) New Material Technology Co. Ltd is a scientific and technological company integrating product research and development manufacturing and trading of chemical intermediates, specialized in organic intermediates, pharmaceutica ...
Common Name: Levamisole (hydrochloride). CAS Number: 16595-80-5. Molecular Weight: 240.752. Boiling Point: 344.4°C at 760 mmHg. Molecular Formula: C11H13CIN2S. Melting Point: 226-231°C. Flash Point: ...
based inMunich, GERMANY
Therawis Pharma GmbH is a privately held, profitable oncology-specialized company with offices located in Munich, Germany, and was founded in April 2014. We provide european-wide support in medical & clinical trial development for therapeutics and ...
Personalized medicine aims to identify patients who require treatment and subsequently select the right therapy based on individual factors and tumor characteristics, i.e. personalized medicine targets to identify the right patients for the right ...
based inPhiladelphia, PENNSYLVANIA (USA)
A clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases Cabaletta Bio seeks to employ its specifically targeted CAAR (Chimeric AutoAntibody Receptor) T ...
Our lead product candidate, DSG3-CAART, is being developed to treat mucosal pemphigus vulgaris (mPV), a blistering skin disease that affects mucous membranes. mPV is caused by autoantibodies that attack the cell adhesion protein desmoglein 3, or ...
based inHouston, TEXAS (USA)
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a public biopharmaceutical company based in the Houston, TX area that is developing GP2, a novel peptide immunotherapy, and has commenced a Phase III clinical trial, called Flamingo-01. GP2 is derived ...
based inShirley, NEW YORK (USA)
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. We provide contract biologic R&D and manufacturing services to the diagnostic manufacturers ...
based inRedwood City, CALIFORNIA (USA)
Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. We’re developing blood tests for early detection in high-risk populations and ...
Our Guardant Reveal™ test is the first blood-only test that detects residual and recurrent disease in two weeks, without the need for a tissue biopsy. The test detects circulating tumor DNA (ctDNA) in blood ...
based inPrinceton, NEW YORK (USA)
We are a biopharmaceutical company dedicated to building novel solutions that treat urothelial and specialty cancers. Our breakthrough therapy and innovative clinical pipeline aim to maximize the potential benefit of local delivery with our novel ...
UroGen is developing UGN-102 (mitomycin) for intravesical solution as a primary nonsurgical alternative to repetitive TURBT. UGN-102 is an investigational formulation that utilizes our innovative technology, RTGel™ reverse-thermal hydrogel, ...
based inEdmonton, ALBERTA (CANADA)
Nanostics is a medical device and biotechnology company with a mission to provide clarity to people about their health by enabling better diagnosis and improving health care decisions through machine learning and extracellular vesicle detection. ...
Our core technology ClarityDX® can: Identify biomarkers expressed by diseased cells/tissues. Indicate if treatment is needed. Predict treatment response and resistance. Stratify disease stage. Identify ...